Trial · NCT03566199
Adverse events73
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 73
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Fatigue | General disorders | Phase 1: Treatment (MTX110) | 4 | 7 | 5 |
| other | Gait disturbance | General disorders | Phase 1: Treatment (MTX110) | 3 | 7 | 5 |
| other | Pain | General disorders | Phase 1: Treatment (MTX110) | 3 | 7 | 8 |
| other | Irritability | General disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
| other | Headache | Nervous system disorders | Phase 1: Treatment (MTX110) | 5 | 7 | 8 |
| other | Ataxia | Nervous system disorders | Phase 1: Treatment (MTX110) | 4 | 7 | 17 |
| other | Dizziness | Nervous system disorders | Phase 1: Treatment (MTX110) | 4 | 7 | 5 |
| other | Abducens nerve disorder | Nervous system disorders | Phase 1: Treatment (MTX110) | 3 | 7 | 4 |
| other | Dysarthria | Nervous system disorders | Phase 1: Treatment (MTX110) | 2 | 7 | 7 |
| other | Facial nerve disorder | Nervous system disorders | Phase 1: Treatment (MTX110) | 2 | 7 | 2 |
| other | Nervous system disorders - Other | Nervous system disorders | Phase 1: Treatment (MTX110) | 2 | 7 | 4 |
| other | Paresthesia | Nervous system disorders | Phase 1: Treatment (MTX110) | 2 | 7 | 2 |
| other | Trigeminal nerve disorder | Nervous system disorders | Phase 1: Treatment (MTX110) | 2 | 7 | 2 |
| other | Vagus nerve disorder | Nervous system disorders | Phase 1: Treatment (MTX110) | 2 | 7 | 2 |
| other | Accessory nerve disorder | Nervous system disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
| other | Aphonia | Nervous system disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
| other | Dysgeusia | Nervous system disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
| other | Dysphasia | Nervous system disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
| other | Glossopharyngeal nerve disorder | Nervous system disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
| other | Tremor | Nervous system disorders | Phase 1: Treatment (MTX110) | 1 | 7 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03566199/events